| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |